Menlo Therapeutics' IPO

Menlo Therapeutics raised a round of funding on January 25, 2018. Investors include Public.

Menlo Therapeutics, formerly Tigercat Pharma, is a clinical stage pharmaceutical company dedicated to the development of serlopitant, a once-daily oral NK-1 receptor antagonist, for the treatment of c…

Articles about Menlo Therapeutics' IPO: